Vol 12, No 12 (2009)

Chinese Journal of Lung Cancer

Table of Contents

Basic Research

Detection and Its Clinical Significance of EGFR Gene Mutation and Gene Amplification in 187 Patients with Non-small Cell Lung Cancer PDF HTML
Hongyu LIU, Ying LI, Gang CHEN, Jing WANG, Yongwen LI, Yuli WANG, Sen WEI, Daxing ZHU, Xiaoming QIU, Weiqiang WANG, Zuoqing SONG, Jun CHEN, Qinghua ZHOU 1219-1228

Clinical Research

Erlotinib in the trentment of Advanced Non-small-cell Lung Cancer: A Systematic Review PDF HTML
Lina ZHU, Zhenjun YANG, Shiyong WANG, Yanming TANG 1229-1236
Pooled Analysis of the Trials of Erlotinib Monotherapy for Epidermal Growth Factor Receptor (EGFR)-mutant Advanced Non-small Cell Lung Cance PDF HTML
Ting WANG, Li MA 1237-1241
Clinical Observation of Erlotnib in the Treatment of Non-small Cell Lung Cancer with Multimetastases in Elderly Patients PDF HTML
Feng ZHANG, Lina XING, You YU, Yanwei MA, Binying ZOU 1242-1246
The Association between EGFR Gene Amplification and the Prognosis in Non-small Cell Lung Cancer: A meta-analysis PDF HTML
Zhijie WANG, Lu YANG, Tongtong AN, Jun ZHAO, Hua BAI, Jianchun DUAN, Meina WU, Minglei ZHUO, Yuyan WANG, Jie WANG 1247-1254
EGFR Mutations Detection in Non-small Cell Lung Cancer Tissues by Real-time PCR and DNA Sequencing PDF HTML
Yongwen LI, Hongyu LIU, Ying LI, Yuli WANG, Jing WANG, Jun CHEN, Qinghua ZHOU 1255-1259
A Systematic Review of Erlotinib for Advanced Non-small Cell Lung Cancer PDF HTML
Huiling GUO, Rongfang ZHANG, Qimei YANG, Lingjuan ZHANG, Kehu YANG, Jinhui TIAN 1260-1265
The Impact of Smoking Status on the Efficacy of Erlotinib in Patients with Advanced Non-small Cell Lung Cancer PDF HTML
Yisheng HUANG, Jinji YANG, Yan YANG, Yujuan HUANG, Riqiang LIAO, Yilong WU 1266-1270
The Analysis of Erlotinib on Brain Metastases in Patients with Non-small-cell Lung Cancer PDF HTML
Hao BAI, Baohui HAN 1271-1275
Clinical Observation of Erlotinib in the Treatment of Advanced and Previously Treated Non-small Cell Lung Cancer PDF HTML
Junfang TANG, Yunzhong ZHU, Zhe LIU, Wei WU, Zan LIU, Heling SHI, Qiyi MENG, Mingzhi LI, Yuhua WU, Liyan XU 1276-1281
Clinical Observation of Erlotinib as the First-line Treatment for Patients with Advanced Non-small Cell Lung Cancerr PDF HTML
Cheng HUANG, Biao WU, Wu ZHUANG, Zhenwu XU, Jing ZHANG, Yunjian HUANG 1282-1286
Clinical Study of Erlotinib in the Treatment of Patients with Advanced Stage Non-small Cell Lung Cancer PDF HTML
Jinjing XIA, Liyan JIAN, Jie ZHANG, Qian MIAO, Yu XIN, Runbo ZHONG, Yizhuo ZHAO, Baohui HAN 1287-1290

Clinical Experience

A Clinical Observation of Concomitant Therapy of Erlotinib and Whole Brain Radiotherapy in Patients of NSCLC Combined with Brain Metastases PDF HTML
Jing ZHAO, Qiang FU, Lihong ZHANG 1291-1294
Observation of Erlotinib in the Treatment of Elderly Patients with Advanced Non-small Cell Lung Cancer and COPD PDF HTML
Qing MA, Li MA, Yan WANG, Fanlu MENG, Linglin ZOU, Huiling ZHANG 1295-1296
Erlotinib as the Second-line Treatment for NSCLC Patients of Stage IIIb/IV PDF HTML
Tian LI 1297-1300
A Retrospective Analysis of Erlotinib and TP/GP Regimen in the Treatment of Advanced Non-small Cell Lung Cancer PDF HTML
Yanxia YANG, Yunqi HUA, Yongjuan WU, Haiqing YUAN 1301-1304
Clinical Observation of Erlotinib in the Treatment of Advanced Non-small Cell Lung Cancer: A Report of 92 Eases PDF HTML
Aiqin GU, Liwen XIONG, Huimin WANG, Chunlei SHI, Zhiqiang GAO, Baohui HAN 1305-1308
A Retrospective Study of Erlotinib in the Treatment of 70 Patients with Non-small Cell Lung Cancer PDF HTML
Yuhua WU, Hong TAO, Junfang TANG, Xinyong ZHANG, Yunzhong ZHU, Zhe LIU, Heling SHI, Qiyi MENG, Wei WU, Zan LIU, Lili GUO, Mingzhi LI, Liyan XU 1309-1311

Journal Watch

Role of miRNAs in Lung Cancer PDF HTML
William C.S. Cho 1312-1315

Minireview

Combined Inhibition of Vascular Endothelial Growth Factor and Epidermal Growth Factor Signaling Pathways in Non–small Cell Lung Cancer Therapy PDF HTML
Juan NAN, Qian LIU, Yan DING, Zhanque ZHANG, Allen C. Gao, Qinghua ZHOU 1316-1324
The Mechanism of Resistance to EGFR-TKI in NSCLC and Exploration to Overcome the Resistance PDF HTML
Jun PEI, Baohui HAN 1325-1329
Erlotinib-induced Skin Rash in Patients with Non–small Cell Lung Cancer: Pathogenesis, Clinical Significance and Treatment PDF HTML
Yan DING, Qian LIU, Juan NAN, Qinghua ZHOU 1330-1336
Erlotinib in Patients with Brain Metastases for Non-small Cell Lung Cancer PDF HTML
Jiandong ZHANG, Xinshuang YU, Jinming YU 1337-1340
Advanced Research on the Response of EGFR Tyrosine Kinase Inhibitors for Non-small Cell Lung Cancer Therapy PDF HTML
Xifeng DONG, Qiang SONG 1341-1345
Mechanisms of Acquired Resisitance to EGFR Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer PDF HTML
Xiaoping LI, Hongjie LI 1346-1351
Progression in Therapy of Erlotinib for Patients with Non-small Cell Lung Cancerr PDF HTML
Fanlu MENG, Li MA 1352-1355
Biomarkers of Patients with Non-small Cell Lung Cancer who Benefited from Erlotinib Treatment PDF HTML
Dali HAN, Jinmimg YU 1356-1358
Advances of Targeted therapies in Non-small Cell Lung Cancer PDF HTML
Ruixiu ZHANG, Yong ZHAO, Zhanque ZHANG 1359-1364
Molecular Predictor to Response and Toxicity of EGFR-targeted Medicines in Lung Cancer PDF HTML
Cunwei CAI 1365-1368
Advances of KRAS Mutation in Non-small Cell Lung Cancer PDF HTML
Yang LI 1369-1373

Case Reports

A Case Report of Erlotinib as First-line Therapy in Extensive Metastatic Patient with Advanced Non-small Cell Lung Cancera PDF HTML
Wanfeng GUO, Xiaoqing LIU 1374-1376


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.